Stay updated with breaking news from Bioasis Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Bioasis Technologies Inc. (OTCMKTS:BIOAF – Get Rating) saw a large growth in short interest in the month of April. As of April 15th, there was short interest totalling 18,800 shares, a growth of 48.0% from the March 31st total of 12,700 shares. Based on an average trading volume of 14,000 shares, the days-to-cover ratio is […]
09.03.2022 - NEW HAVEN, Conn., March 09, 2022 (GLOBE NEWSWIRE) - BIOASIS TECHNOLOGIES INC. (TSXV:BTI; OTCQB:BIOAF), (the “Company” or “Bioasis”), a biopharmaceutical company developing its proprietary xB3 platform technology for the delivery of therapeutics ... Seite 1
The World Health Organization estimates that neurological disorders cause 12 per cent of the world’s deaths
Blood-Brain Barrier (BBB) Market Size, Growth, Revenue, Demand, Share and Key Companies Valuation by 2028
BiOasis: Fiscal Q1 Earnings Snapshot July 30, 2021 FacebookTwitterEmail NEW HAVEN, Conn. (AP) _ Bioasis Technologies Inc. (BIOAF) on Thursday reported a loss of $440,000 in its fiscal first quarter. On a per-share basis, the New Haven, Connecticut-based company said it had a loss of 1 cent. The company's shares closed at 25 cents. A year ago, they were trading at 22 cents. _____ This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on BIOAF at https://www.zacks.com/ap/BIOAF ...